The new policy of Facebook on its comments feature somehow caused alarm to Pharmaceutical marketers making some of them now having second thought of maximizing social media strategy. Facebook recently sent letters to pharmaceutical companies informing them that they are no longer allowed to stop the comments features on their respective pages effective August 15. The news came shocking and somewhat hurt many big pharma marketers especially those who are using social media like Facebook as part of its marketing strategies. Most of these pharmaceutical marketers are apprehensive of Facebook’s…
Read MoreFacebook’s new policy gives big pharma second thought on social media strategy
